Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Gains from Sales and Divestitures (2021 - 2026)

TELA Bio has reported Gains from Sales and Divestitures over the past 5 years, most recently at $279765.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 46.34% year-over-year to $279765.0; the TTM value through Dec 2025 reached $279765.0, up 46.34%, while the annual FY2025 figure was $279765.0, 46.34% up from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $279765.0 at TELA Bio, up from $268601.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $279765.0 in Q4 2025 and troughed at $12000.0 in Q2 2021.
  • A 5-year average of $117153.5 and a median of $99684.0 in 2023 define the central range for Gains from Sales and Divestitures.
  • Biggest five-year swings in Gains from Sales and Divestitures: soared 239.86% in 2022 and later skyrocketed 40.61% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $12000.0 in 2021, then soared by 239.86% to $40783.0 in 2022, then surged by 149.02% to $101559.0 in 2023, then surged by 88.24% to $191175.0 in 2024, then skyrocketed by 46.34% to $279765.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for TELA at $279765.0 in Q4 2025, $268601.0 in Q3 2025, and $231011.0 in Q2 2025.